4.7 Article

European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantation

Related references

Note: Only part of the references are listed.
Article Oncology

Comprehensive genetic analysis of donor cell derived leukemia with KMT2A rearrangement

Rieko Taniguchi et al.

PEDIATRIC BLOOD & CANCER (2018)

Article Medicine, General & Internal

cute Megakaryoblastic Leukemia Developing as Donor Cell Leukemia after Umbilical Cord Blood Transplantation

Yoshitaka Adachi et al.

INTERNAL MEDICINE (2018)

Letter Biophysics

Inadvertent transmission of occult CML through allo-SCT

M. D. de Brito et al.

BONE MARROW TRANSPLANTATION (2015)

Article Hematology

Comprehensive characterization of mesenchymal stromal cells from patients with Fanconi anaemia

Melissa Mantelli et al.

BRITISH JOURNAL OF HAEMATOLOGY (2015)

Review Hematology

Donor Cell Leukemia: A Review

Daniel H. Wiseman

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)

Article Multidisciplinary Sciences

Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia

Marc H. G. P. Raaijmakers et al.

NATURE (2010)

Letter Biophysics

Therapy-related, donor-derived AML responding to a second allogeneic BMT

J. F. M. Jacobs et al.

BONE MARROW TRANSPLANTATION (2007)

Article Hematology

Evidence of donor-derived hematologic malignancies after hematopoietic stem cell transplantation

O Sala-Torra et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)